Jeremy Chapman

Q: What Schools Are Affiliated With Jeremy Chapman

Jeremy Chapman is affiliated with the following schools: University of Sydney, University of Melbourne, University of Cambridge

Jeremy Chapman's AcademicInfluence.com Rankings

Jeremy Chapman

Philosophy

#5657

World Rank

#8524

Historical Rank

Logic

#3927

World Rank

#5157

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jeremy Chapman's Degrees

Masters Medicine University of Melbourne

Why Is Jeremy Chapman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jeremy Robert Chapman is a British–Australian nephrologist, renal physician and transplant surgeon. He has been the director of the Division of Medicine and Cancer at Westmead Hospital in Sydney since 2007.

(See a Problem?)

Jeremy Chapman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. (2010) (1762)
The natural history of chronic allograft nephropathy. (2003) (942)
Cancer incidence before and after kidney transplantation. (2006) (831)
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation (2013) (687)
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data (2005) (547)
Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology (2004) (477)
Chronic renal allograft dysfunction. (2005) (448)
Chronic Allograft Nephropathy: Current Concepts and Future Directions (2006) (339)
Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials (2006) (331)
Predicting glomerular filtration rate after kidney transplantation. (1995) (297)
EFFECT OF HISTOLOGICAL DAMAGE ON LONG-TERM KIDNEY TRANSPLANT OUTCOME (2001) (276)
How can we achieve global equity in provision of renal replacement therapy? (2008) (267)
Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. (2005) (265)
Natural History, Risk Factors, and Impact of Subclinical Rejection in Kidney Transplantation (2004) (260)
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. (2010) (260)
Cancer in the transplant recipient. (2013) (236)
Identifying High Risk Groups and Quantifying Absolute Risk of Cancer After Kidney Transplantation: A Cohort Study of 15 183 Recipients (2007) (232)
Association of CKD and cancer risk in older people. (2009) (227)
The pattern of excess cancer in dialysis and transplantation. (2009) (191)
Survival of DNA HLA-DR typed and matched cadaver kidney transplants (1991) (183)
Organ trafficking and transplant tourism and commercialism : the declaration of Istanbul (2008) (170)
Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities (2012) (169)
The Significance of Subclinical Rejection and the Value of Protocol Biopsies (2006) (168)
Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials1 (2004) (168)
International practices of organ donation. (2012) (159)
EARLY CYCLOSPORINE WITHDRAWAL FROM A SIROLIMUS-BASED REGIMEN RESULTS IN BETTER RENAL ALLOGRAFT SURVIVAL AND RENAL FUNCTION AT 48 MONTHS AFTER TRANSPLANTATION (2004) (158)
The critical pathway for deceased donation: reportable uniformity in the approach to deceased donation (2011) (153)
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study (2010) (151)
Interleukin 2 receptor antagonists for kidney transplant recipients. (2004) (147)
Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the rapamune maintenance regimen study12 (2003) (143)
MORPHOMETRIC ANALYSIS OF CELLULAR INFILTRATION ASSESSED BY MONOCLONAL ANTIBODY LABELING IN SEQUENTIAL HUMAN RENAL ALLOGRAFT BIOPSIES (1986) (138)
Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study (2016) (136)
The motivations and experiences of living kidney donors: a thematic synthesis. (2012) (136)
Chronic Calcineurin Inhibitor Nephrotoxicity—Lest We Forget (2011) (134)
Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study (2011) (133)
The global role of kidney transplantation. (2012) (132)
Interleukin 2 receptor antagonists for kidney transplant recipients. (2010) (129)
Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras (2016) (129)
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. (2009) (121)
Predictors of renal transplant histology at three months. (1999) (121)
Belatacept for kidney transplant recipients. (2014) (118)
Exercise Training in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis (2013) (116)
A Report of the Lisbon Conference on the Care of the Kidney Transplant Recipient (2007) (114)
Clinical Practice Guidelines on Wait-Listing for Kidney Transplantation: Consistent and Equitable? (2012) (114)
Protocol Biopsies in Renal Transplantation: Insights into Patient Management and Pathogenesis (2007) (111)
Cancer in kidney transplant recipients (2018) (109)
Reduced estimated GFR and cancer mortality. (2014) (108)
Early cyclosporine withdrawal from a sirolimus‐based regimen results in better renal allograft survival and renal function at 48 months after transplantation (2005) (107)
Guidelines for the Diagnosis of Antibody‐Mediated Rejection in Pancreas Allografts—Updated Banff Grading Schema (2011) (106)
Delta Analysis of Posttransplantation Tubulointerstitial Damage (2004) (106)
Cancer screening in renal transplant recipients: what is the evidence? (2008) (105)
Renal graft thrombosis. A survey of 134 consecutive cases. (1994) (103)
Cancers after renal transplantation. (2008) (103)
Diabetic neuropathy after pancreas transplantation: determinants of recovery. (1997) (101)
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. (2006) (101)
Estimated One-Year Glomerular Filtration Rate is the Best Predictor of Long-term Graft Function Following Renal Transplant (2006) (100)
Treatment of Subclinical Rejection Diagnosed by Protocol Biopsy of Kidney Transplants (2006) (99)
Screening and Follow-Up of Living Kidney Donors: A Systematic Review of Clinical Practice Guidelines (2011) (98)
The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i‐IFTA lesion (2018) (98)
The Role of Macrophages in the Development of Human Renal Allograft Fibrosis in the First Year After Transplantation (2014) (93)
A Survey of Families of Brain Dead Patients: Their Experiences, Attitudes to Organ Donation and Transplantation (1995) (91)
The KDIGO clinical practice guidelines for the care of kidney transplant recipients. (2010) (89)
Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation. (1998) (89)
Organ Trafficking and Transplant Tourism: The Role of Global Professional Ethical Standards—The 2008 Declaration of Istanbul (2013) (88)
Diabetic retinopathy after combined kidney–pancreas transplantation (1999) (86)
The global diffusion of organ transplantation: trends, drivers and policy implications (2014) (86)
Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation. (2008) (85)
Immunosuppression and Other Risk Factors for Lip Cancer after Kidney Transplantation (2009) (82)
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance. (2007) (82)
Surveillance Protocol Kidney Transplant Biopsies: Their Evolving Role in Clinical Practice (2011) (79)
Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial (2006) (78)
Monoclonal and Polyclonal Antibody Therapy for Treating Acute Rejection in Kidney Transplant Recipients: A Systematic Review of Randomized Trial Data (2006) (78)
SEQUENTIAL ANALYSIS OF HLA‐CLASS II ANTIGEN EXPRESSION IN HUMAN RENAL ALLOGRAFTS Induction of Tubular class II Antigens and Correlation with Clinical Parameters (1986) (77)
Evolution and Pathophysiology of Renal-Transplant Glomerulosclerosis (2004) (76)
Research Priorities in CKD: Report of a National Workshop Conducted in Australia. (2015) (73)
ORAL CYCLOSPORINE BUT NOT TACROLIMUS REDUCES RENAL TRANSPLANT BLOOD FLOW (2004) (73)
Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients (2009) (73)
Recurrence of cancer after renal transplantation. (2001) (70)
Human Islets Express a Marked Proinflammatory Molecular Signature Prior to Transplantation (2012) (70)
Compliance: the patient, the doctor, and the medication? (2004) (69)
BK Virus Nephropathy: Histological Evolution by Sequential Pathology (2017) (67)
Qualitative Research in Organ Transplantation: Recent Contributions to Clinical Care and Policy (2013) (67)
Overall and Site-Specific Cancer Mortality in Patients on Dialysis and after Kidney Transplant. (2019) (66)
The clinical and pathological significance of borderline T cell–mediated rejection (2019) (66)
PERCUTANEOUS BIOPSY OF BLADDER‐DRAINED PANCREAS TRANSPLANTS (1991) (65)
Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants. (1993) (65)
Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology—Kidney Transplantation Consensus Workshops (2017) (65)
Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies (2016) (63)
Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy. (1994) (63)
Estimating the total incidence of kidney failure in Australia including individuals who are not treated by dialysis or transplantation. (2013) (62)
Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals (2017) (60)
HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients. (2016) (60)
Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy. (2007) (60)
The Impact of Total Ischemic Time, Donor Age and the Pathway of Donor Death on Graft Outcomes After Deceased Donor Kidney Transplantation (2017) (59)
Twin- versus single-bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis. (1996) (59)
The mechanism of cyclosporine toxicity induced by clarithromycin. (2003) (58)
Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations. (2005) (57)
The global role of kidney transplantation. (2013) (57)
Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis (2016) (56)
Acute Rejection, T-Cell–Depleting Antibodies, and Cancer After Transplantation (2014) (56)
Mycophenolate Versus Azathioprine for Kidney Transplantation: A 15-Year Follow-Up of a Randomized Trial (2012) (53)
Association Between Delayed Graft Function and Graft Loss in Donation After Cardiac Death Kidney Transplants—A Paired Kidney Registry Analysis (2017) (52)
DNA HLA-DR typing results of 4000 kidney transplants. (1993) (52)
Peak Panel Reactive Antibody, Cancer, Graft, and Patient Outcomes in Kidney Transplant Recipients (2015) (51)
The Expectations and Attitudes of Patients With Chronic Kidney Disease Toward Living Kidney Donor Transplantation: A Thematic Synthesis of Qualitative Studies (2015) (51)
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? (2006) (51)
Follow‐up after renal transplantation with organs from donors after cardiac death (2006) (51)
‘Suspended in a paradox’—patient attitudes to wait‐listing for kidney transplantation: systematic review and thematic synthesis of qualitative studies (2015) (51)
Epithelial-to-mesenchymal transition in early transplant tubulointerstitial damage. (2008) (50)
Progression of macrovascular disease after transplantation. (2000) (49)
Time on Dialysis and Cancer Risk After Kidney Transplantation (2013) (48)
The Seville expert workshop for progress in posttransplant lymphoproliferative disorders. (2012) (48)
Once-Daily Extended-Release Versus Twice-Daily Standard-Release Tacrolimus in Kidney Transplant Recipients: A Systematic Review (2013) (47)
Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous Cancer (2015) (47)
Perspectives of Older Kidney Transplant Recipients on Kidney Transplantation. (2017) (46)
Motivations, experiences, and perspectives of bone marrow and peripheral blood stem cell donors: thematic synthesis of qualitative studies. (2013) (46)
One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST Observational Study. (2003) (46)
Post-transplant Pneumocystis jirovecii pneumonia--a re-emerged public health problem? (2013) (45)
Public Awareness and Attitudes to Living Organ Donation: Systematic Review and Integrative Synthesis (2013) (45)
Individualization of immunosuppression: concepts and rationale (2008) (44)
The Health and Economic Impact of Cervical Cancer Screening and Human Papillomavirus Vaccination in Kidney Transplant Recipients (2009) (44)
Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous Immunoglobulin (2017) (44)
Cost-Effectiveness of Colorectal Cancer Screening in Renal Transplant Recipients (2008) (44)
The experiences of commercial kidney donors: thematic synthesis of qualitative research (2012) (42)
Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression. (1987) (42)
Validity of registry data: Agreement between cancer records in an end‐stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting) (2010) (41)
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. (2006) (41)
Screening for renal cancer in recipients of kidney transplants. (2010) (41)
Incidence of anemia in sirolimus‐treated renal transplant recipients: the importance of preserving renal function * (2007) (41)
What are the key challenges we face in kidney transplantation today? (2013) (40)
Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysis. (1991) (40)
The Preferences and Perspectives of Nephrologists on Patients’ Access to Kidney Transplantation: A Systematic Review (2014) (39)
Mortality among Younger and Older Recipients of Kidney Transplants from Expanded Criteria Donors Compared with Standard Criteria Donors. (2016) (38)
Potential for cadaveric organ retrieval in New South Wales. (1992) (38)
Third WHO Global Consultation on Organ Donation and Transplantation: striving to achieve self-sufficiency, March 23–25, 2010, Madrid, Spain. (2011) (38)
Organ and Tissue Donation for Transplantation (1997) (38)
Transplantomics and Biomarkers in Organ Transplantation: A Report From the First International Conference (2011) (37)
Knowledge, beliefs and attitudes of kidney transplant recipients regarding their risk of cancer (2012) (37)
Increased incidence of squamous cell carcinoma of eye after kidney transplantation. (2007) (37)
Factors in older cadaveric organ donors impacting on renal allograft outcome (1999) (37)
How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study (2013) (37)
Sirolimus: Its role in nephrology (Review Article) (2005) (35)
Association of Fc Gamma Receptor IIA Polymorphisms with Acute Renal-Allograft Rejection (2004) (35)
Tirofiban and Activated Protein C Synergistically Inhibit the Instant Blood Mediated Inflammatory Reaction (IBMIR) from Allogeneic Islet Cells Exposure to Human Blood (2009) (34)
Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplant using a microemulsion formulation. (1996) (33)
Simultaneous pancreas and kidney transplant rejection: separate or synchronous events? (1997) (33)
Cancer After Renal Transplantation: The Next Challenge (2004) (33)
Predicting glomerular filtration rate after simultaneous pancreas and kidney transplantation. (1995) (33)
The global role of kidney transplantation (2011) (33)
Detection of chronic allograft nephropathy by quantitative doppler imaging (2002) (33)
The cytokine and histological response in islet xenograft rejection is dependent upon species combination. (1997) (32)
The risk of cancer in people with diabetes and chronic kidney disease. (2012) (30)
Diagnosis of kidney transplant obstruction using Mag3 diuretic renography (2001) (30)
Posttransplant cataract: lessons from kidney-pancreas transplantation. (2000) (30)
Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation (2016) (30)
Identifying Outcomes that Are Important to Living Kidney Donors: A Nominal Group Technique Study. (2018) (30)
The Risk of Cancer in Recipients of Living-Donor, Standard and Expanded Criteria Deceased Donor Kidney Transplants: A Registry Analysis (2014) (30)
Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection? (2018) (29)
Cost-effectiveness of breast cancer screening in women on dialysis. (2008) (29)
World Kidney Day 2012: the global role of kidney transplantation. (2012) (29)
Clinical Utility of Urinary Cytology to Detect BK Viral Nephropathy (2015) (29)
Death from cancer: a sobering truth for patients with kidney transplants. (2014) (28)
Delayed graft function: risk factors, consequences and parameters affecting outcome-results from MOST, A Multinational Observational Study. (2005) (28)
Perspectives of transplant physicians and surgeons on reimbursement, compensation, and incentives for living kidney donors. (2014) (28)
Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. (2011) (28)
Transcriptome Changes of Chronic Tubulointerstitial Damage in Early Kidney Transplantation (2010) (28)
Do protocol transplant biopsies improve kidney transplant outcomes? (2012) (27)
Open letter to Xi Jinping, President of the People's Republic of China: China's fight against corruption in organ transplantation. (2014) (27)
Patient experiences of training and transition to home haemodialysis: A mixed‐methods study (2017) (26)
Donor and Recipient Views on Their Relationship in Living Kidney Donation: Thematic Synthesis of Qualitative Studies. (2017) (26)
HLA-DR and -DQ genotyping in anti-GBM disease. (1991) (26)
Research priority setting in organ transplantation: a systematic review (2017) (26)
Chronic allograft nephropathy--clinical guidance for early detection and early intervention strategies. (2008) (26)
China organ donation and transplantation update: the Hangzhou Resolution. (2014) (26)
Fatal Mycotic Aneurysms Due to Scedosporium and Pseudallescheria Infection (2011) (25)
Range and Consistency of Outcomes Reported in Randomized Trials Conducted in Kidney Transplant Recipients: A Systematic Review (2018) (24)
Genetic and functional evaluation of the level of inbreeding of the Westran pig: a herd with potential for use in xenotransplantation (2005) (24)
The Blood Pressure Lowering Treatment Trialists' Collaboration (2001) (23)
The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation (2016) (22)
'I feel stronger and younger all the time'-perspectives of elderly kidney transplant recipients: thematic synthesis of qualitative research. (2016) (22)
Reported cancer screening practices of nephrologists: results from a national survey. (2009) (22)
The Global Role of Kidney Transplantation for the World Kidney Day Steering Committee 2012 (2012) (22)
Renal transplant outcomes and de novo donor-specific anti-human leukocyte antigen antibodies: a systematic review (2018) (22)
How do people with chronic kidney disease value cancer‐related quality of life? (2012) (21)
INCIDENCE, RISK AND PREDICTORS OF CANCER AFTER RENAL TRANSPLANTATION; AN ANALYSIS OF ANZDATA, THE AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY. (2004) (21)
Sirolimus: its role in nephrology. (2005) (21)
Economic Evaluations in Kidney Transplantation: Frequency, Characteristics, and Quality—A Systematic Review (2014) (21)
Percutaneous pancreas transplant fine needle aspiration and needle core biopsies are useful and safe. (1990) (21)
Manual of Renal Transplantation (1994) (20)
Clinical determinants of glucose homeostasis after pancreas transplantation. (1996) (20)
Nephrologists' Perspectives on Recipient Eligibility and Access to Living Kidney Donor Transplantation (2016) (20)
DELAYED GRAFT FUNCTION: RISK FACTORS, CONSEQUENCES AND PARAMETERS AFFECTING OUTCOME. RESULTS FROM MOST, A MULTINATIONAL OBSERVATIONAL STUDY. (2004) (20)
The Global role of kidney transplantation. (2012) (19)
Erythrocytosis after renal transplantation: risk factors and relationship with GFR. (1995) (19)
Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. (2013) (19)
No excess risk of follicular lymphoma in kidney transplant and HIV‐related immunodeficiency (2010) (18)
Chronic allograft nephropathy – a clinical syndrome: early detection and the potential role of proliferation signal inhibitors (2009) (18)
Geographic variance in access to renal transplantation in Australia (2003) (18)
The Lived Experience of "Being Evaluated" for Organ Donation: Focus Groups with Living Kidney Donors. (2017) (17)
Malignancy in renal transplantation: opportunities with proliferation signal inhibitors Guest editors’ introduction (2007) (17)
Health-Related Quality of Life in People Across the Spectrum of CKD (2020) (17)
Clinical renal transplantation: where are we now, what are our key challenges? (2010) (17)
Public Attitudes and Beliefs About Living Kidney Donation: Focus Group Study (2014) (16)
Renal transplantation: better fat than thin. (2015) (16)
The global role of kidney transplantation. (2012) (16)
Recruitment and retention in clinical trials in chronic kidney disease: report from national workshops with patients, caregivers and health professionals. (2020) (16)
Costs of immunosuppressive therapies used in renal transplantation. (1992) (16)
Management of indwelling catheters. (1975) (16)
Recovery of diabetic neuropathy after pancreas transplantation. (1997) (15)
Clinician's Manual on Blood Pressure and Stroke Prevention (2002) (15)
One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study). (2019) (15)
Induction of Allogeneic Islet Tolerance in a Large-Animal Model (2000) (15)
The global role of kidney transplantation. (2012) (15)
Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation (2013) (15)
Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation. (2009) (15)
Why do patients develop proteinuria with sirolimus? Do we have the answer? (2010) (15)
Obtaining Consent for Organ Donation in Nine NSW Metropolitan Hospitals (1995) (15)
Longitudinal histopathologic assessment of rejection after bladder-drained canine pancreas allograft transplantation. (1991) (15)
Access to waitlisting for deceased donor kidney transplantation in Australia (2019) (14)
The Global Role of Kidney Transplantation (2012) (14)
Human organ and tissue transplantation. Commentary (2005) (14)
Globally consistent coding systems for medical products of human origin. (2013) (14)
Organs From Executed People Are Not a Source of Scientific Discovery. (2019) (14)
O papel global do transplante renal (2012) (14)
Should we pay donors to increase the supply of organs for transplantation? No (2008) (13)
Why do pancreas transplants thrombose? (2001) (13)
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. (2017) (13)
The KDIGO review of the care of renal transplant recipient. (2010) (13)
Maintenance therapy with oral ganciclovir after treatment of cytomegalovirus infection. (1998) (13)
“Proposed Standards for Incentives for Organs Donation” Are Neither International nor Acceptable (2012) (12)
Experimental hyperacute rejection in pancreas allotransplants. (1996) (12)
The global role of kidney transplantation. (2012) (12)
Can Cadaveric Organ Donation Rates be Improved? (1995) (12)
Progress in Transplantation: Will It Be Achieved in Big Steps or by Marginal Gains? (2017) (12)
The Identification of Potential Cadaveric Organ Donors (1995) (12)
The consequences of successful transplantation (2011) (12)
Mercaptoacetyltriglycine diuretic renography and output efficiency measurement in renal transplant patients (1999) (11)
Expectations and Experiences of Follow-up and Self-Care After Living Kidney Donation: A Focus Group Study (2017) (11)
A decision‐analytic economic evaluation of valaciclovir prophylaxis for the prevention of cytomegalovirus infection and disease in renal transplantation (2004) (11)
Invasive Fungal Infections after Renal Transplantation (2012) (11)
Adenine Phosphoribosyltransferase Deficiency: A Potentially Reversible Cause of CKD (2019) (11)
Principles and strategies for involving patients in research in chronic kidney disease: report from national workshops. (2020) (11)
Excellent Outcomes of Simultaneous Pancreas Kidney Transplantation in Patients From Rural and Urban Australia: A National Service Experience (2012) (11)
Cost-Effectiveness of Cidofovir Treatment of Polyomavirus Nephropathy in Kidney Transplant Recipients (2012) (11)
The global role of kidney transplantation. (2012) (11)
Optimizing the long-term outcome of renal transplants: opportunities created by sirolimus. (2003) (11)
The global role of kidney transplantation (2012) (11)
A Large-Animal Model to Evaluate the Clinical Potential of Fetal Pig Pancreas Fragment Transplantation (2000) (10)
Biopsy of potential cadaveric renal allografts at the time of retrieval (2005) (10)
Factors affecting urinary amylase excretion after pancreas transplantation. (1990) (10)
The potential role of xenogeneic antigen‐presenting cells in T‐cell co‐stimulation (1996) (10)
Factors affecting measurement of urinary amylase after bladder-drained pancreas transplantation (1991) (10)
The Relative Benefits and Costs of Solid Phase Bead Technology to Detect Preformed Donor Specific Antihuman Leukocyte Antigen Antibodies in Determining Suitability for Kidney Transplantation (2015) (10)
Transplantation in Australia — 50 years of progress (1992) (10)
The Global Role of Kidney Transplantation (2012) (10)
Validation of a phospholipase A2 receptor antibody ELISA in an Australian cohort with membranous glomerulonephritis. (2016) (10)
Relative survival and quality of life benefits of pancreas–kidney transplantation, deceased kidney transplantation and dialysis in type 1 diabetes mellitus—a probabilistic simulation model (2020) (9)
Debate on financial incentives is off the mark of national and international realities. (2010) (9)
How is Health Economics Relevant to Transplant Clinicians? (2014) (9)
Statement of the Declaration of Istanbul Custodian Group Regarding Payments to Families of Deceased Organ Donors (2016) (9)
Focus group study of public opinion about paying living kidney donors in Australia. (2015) (9)
Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system? (2017) (9)
A survey on the prevalence and management of hepatitis B after renal transplantation in Asian-Pacific countries. (2004) (9)
Glucose homeostasis standards for pancreas transplantation. (1998) (9)
Addressing the challenges for improving long-term outcomes in renal transplantation. (2008) (9)
Successful obstetric outcome after simultaneous pancreas and kidney transplantation (1999) (9)
Pancreas and islet transplantation: an unfinished journey. (2001) (9)
Hypertension in the twentieth century: concepts and achievements (2004) (9)
Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned (2016) (8)
Organ donation: a chance for Australia to do better (2006) (8)
Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption. (1996) (8)
Histological injury and renal transplant outcome: the cumulative damage hypothesis. (2001) (8)
Organ Transplantation in China. (2015) (7)
Human Islets Express a Marked Pro-Inflammatory Molecular Signature Prior to Transplantation: 1320 (2012) (7)
Severity of liver transplantation rejection is associated with recipient HLA type. (1992) (7)
The Lived Experience of ‘Being Evaluated’ for Organ Donation: Focus Groups with Living Kidney Donors (2017) (7)
Kidney donation and transplantation in Australia: more than a supply and demand equation (2018) (7)
Maternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantation. (2016) (7)
The Global Alliance for Transplantation (2005) (7)
Splenunculus masquerading as a neuroendocrine tumor of the pancreatic allograft in a kidney-pancreas recipient. (2013) (7)
Visual Abstracts (#VisualAbstract): A New Journal Initiative to Disseminate Research. (2019) (7)
Informative for Decision Making? The Spectrum and Consistency of Outcomes After Living Kidney Donation Reported in Trials and Observational Studies (2019) (7)
Analysis of rare HLA-DRB1-DQB1 haplotypes in kidney donors and recipients. (1995) (7)
Enteric‐coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients (2013) (6)
Integrative Analysis of Prognostic Biomarkers for Acute Rejection in Kidney Transplant Recipients. (2020) (6)
Comparison of serological and DNA HLA‐DR typing results for transplantation in Western Europe, Eastern Europe, North America and South America (1994) (6)
Simple Vaccination Is not Enough for the Transplant Recipient (2022) (6)
Autolymphocytotoxins and virus infection in renal transplantation. (1987) (6)
Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression* (2008) (6)
Care of Transplant Recipients in Primary Practice. (2016) (6)
The global role of kidney transplantation. (2012) (6)
Renal dysfunction in acute rejection. Effect of HLA typing, therapy, and histology. (1995) (6)
Inhibition of PHA induced mononuclear cell proliferation by FK506 in combination with cyclosporine, methylprednisolone, 6-mercaptopurine and mycophenolic acid. (1993) (6)
Doppler assessment in renal transplantation. (1989) (6)
Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol (2011) (6)
The global role of kidney transplantation (2012) (6)
"Go on--say yes": a publicity campaign to increase commitment to organ donation on the driver's license in New South Wales. (1991) (6)
Impact of deceased donor with acute kidney injury on subsequent kidney transplant outcomes–an ANZDATA registry analysis (2021) (6)
Analysis of discrepancies between serologic and DNA-RFLP typing for HLA-DR in kidney graft recipients. (1992) (5)
The global role of kidney transplantation. (2012) (5)
DNA typing of 3500 cadaver kidney transplants does not confirm the "DR6 effect". (1993) (5)
Deceased Kidney Donor Suitability Guidelines (2005) (5)
Clinicians’ attitudes and approaches to evaluating the potential living kidney donor‐recipient relationship: An interview study (2019) (5)
The Pathophysiology and Impact of Inflammation in Nonscarred Renal Interstitium: The Banff i Lesion (2020) (5)
Factors Associated With Advanced Colorectal Neoplasia in Patients With CKD. (2021) (5)
Perspectives of Transplant Professionals on the Values, Ethics, and Challenges of Living Kidney Donor Evaluation in Asia (2015) (5)
Assessment of renal function after kidney transplantation (1996) (5)
Bortezomib in ABO‐incompatible kidney transplant desensitization: A case report (2015) (5)
Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study. (2006) (5)
Are kidney and pancreas rejection simultaneous events in combined transplants in dogs? (1990) (5)
Survival and Quality of Life Impact of a Risk-based Allocation Algorithm for Deceased Donor Kidney Transplantation (2018) (5)
Donor-transmitted, donor-derived, and de novo cancer after liver transplant. (2014) (5)
In vitro assessment of triple-therapy immunosuppression and prostaglandin analogues enisoprost and misoprostol. (1992) (5)
Cumulative Doses of T-Cell Depleting Antibody and Cancer Risk after Kidney Transplantation (2015) (5)
Questioning the myth: benefits of renin-angiotensin system blockade in kidney transplant recipients. (2014) (4)
SURVIVAL BENEFITS OF KIDNEY TRANSPLANTATION: ABSOLUTE AGAINST INCREMENTAL GAINS IN LIFE YEARS: 1063 (2010) (4)
FK 506 in canine renal transplantation. (1992) (4)
Patient and center characteristics associated with kidney transplant outcomes: a binational registry analysis (2020) (4)
Elective cyclosporine conversion from triple therapy. (1989) (4)
Disease of the Month Chronic Renal Allograft Dysfunction (2005) (4)
The Global Role of Kidney Transplantation (2012) (4)
Marginal kidneys for transplantation (2015) (4)
Analysis of mRNA in renal allografts using polymerase chain reaction amplification. (1992) (4)
A large-animal model to evaluate the clinical potential of fetal pig pancreas fragment transplantation. (2000) (4)
The global alliance for transplantation. (2005) (4)
Sirolimus: searching for its niche or a therapy that has come of age? (2001) (4)
Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients. (2018) (4)
The global role of kidney transplantation (2012) (4)
Paired kidney exchange: how far and how wide? (2008) (4)
Transplanting People with a Prior History of Cancer: An Analysis of the Australian and New Zealand Dialysis and Transplant (ANZDATA) Registry: 2298 (2012) (4)
Non‐heart–beating donors (2005) (3)
Blood pressure lowering for the prevention of first stroke (2002) (3)
The Impact of COVID-19 on the State of Clinical and Laboratory Research Globally in Transplantation in May 2020 (2020) (3)
Seeking to Close the Loopholes in Transplant Tourism and Organ Trafficking. (2018) (3)
Urinary amylase measurement for detection of bladder-drained pancreas allograft rejection. (1990) (3)
Can incremental scoring of fine-needle aspirates predict histopathologic renal allograft rejection? (1988) (3)
RATES OF HUMAN PAPILLOMAVIRUS (HPV)-RELATED CANCERS ARE INCREASED IN RENAL TRANSPLANT RECIPIENTS AND RETURN TO LOW LEVELS ON CESSATION OF IMMUNE SUPPRESSION.: 845 (2008) (3)
The global role of kidney transplantation. (2012) (3)
Commentary: The World Health Assembly resolution on human organ and tissue transplantation. (2010) (3)
Pretreatment of canine whole pancreas allografts with monoclonal antibodies does not prolong graft survival. (1990) (3)
Irritable bowel syndrome: is a barium enema necessary? (1986) (3)
The CARI guidelines. Deceased kidney donor suitability guidelines. (2005) (3)
The Recipient of a Renal Transplant (2019) (3)
Can the risk of skin cancer after transplantation be reduced by mTOR Inhibitors? (2013) (3)
Tolerance Induction in a Large-Animal Model Using Total Lymphoid Irradiation and Intrathymic Bone Marrow (2008) (3)
CURRENCY OF RECEIPT OF IMMUNOSUPPRESSIVE AGENTS AND OTHER RISK FACTORS FOR LIP CANCER FOLLOWING RENAL TRANSPLANTATION: 287 (2008) (3)
PHARMACOKINETIC ANALYSIS OF THE EFFECT OF TWO WEEKS OF SIROLIMUS THERAPY ON CYCLOSPORINE NEORAL BLOOD LEVELS (1999) (3)
Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies (2016) (3)
Weekend effect on early allograft outcome after kidney transplantation‐ a multi‐centre cohort study (2018) (3)
Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: analysis of the MOST database. (2005) (3)
Techniques of economic analysis in psychiatric practice. (1979) (3)
Introduction: Targets for Improving Outcomes in Renal Allografts Transplanted During the Next Ten Years (2008) (3)
Development of blood pressure lowering therapy from trials to practice (2004) (3)
Advantages and disadvantages of pancreas transplantation. (1992) (3)
T-cell receptor V gamma and V delta gene expression in serial renal allograft biopsies. (1994) (3)
The needs for a Global Alliance for Transplantation. (2005) (3)
Immunosuppressive and diabetogenic effect of FK 506 on pancreatic islet xenotransplantation. (1995) (3)
Improving organ donor rates (1999) (3)
Effective strategies to prevent cytomegalovirus disease after renal transplantation. (2000) (2)
The global role of kidney transplantation (2012) (2)
Clusterin and Other Urinary Proteins as Predictive Biomarkers of Long Term Fibrosis and Function in Kidney Recipients: 1383 (2012) (2)
Transplantation practice has been particularly suited to national, regional, specialist and global registries. (2013) (2)
TOR-INHIBITORS (SIROLIMUS AND EVEROLIMUS) FOR PRIMARY IMMUNOSUPPRESSION OF RENAL TRANSPLANT RECIPIENTS: A META-ANALYSIS RANDOMISED TRIALS. (2004) (2)
A different view of sensitization after renal transplant rejection? (2001) (2)
THE ROLE OF EPITHELIAL-TO-MESENCHYMAL TRANSITION IN TRANSPLANT TUBULOINTERSTITIAL DAMAGE, THE FIRST 12 MONTHS: 171 (2008) (2)
Nocardia asteroides causing vena caval obstruction. (1981) (2)
Chronic allograft dysfunction (2015) (2)
Autosomal dominant polycystic kidney disease (ADPKD) is associated with coronary arterial dilatation in end-stage renal failure patients (2012) (2)
RISK FOR NON-HODGKIN LYMPHOMA FOLLOWING RENAL TRANSPLANTATION IS ASSOCIATED WITH CURRENCY OF RECEIPT OF IMMUNOSUPPRESSION AND REVERTS TO NORMAL ON CESSATION: 841 (2008) (2)
Association between delayed graft function and graft loss in donation after cardiac death kidney transplants - a paired kidney registry analysis. (2016) (2)
Current issues of IP management for health and agriculture in Japan. (2007) (2)
The global role of kidney transplantation. (2012) (2)
Ethical Issues in Unrelated Cord Blood and Bone Marrow Donation (2009) (2)
Nephrologistsʼ Preferences and Perspectives On Patientsʼ Access to Kidney Transplantation: A Systematic Review.: Abstract# B834 (2014) (2)
Transplantation Reaches 100th Volume. (2016) (2)
Cancer in patients with inherited ciliopathies: polycystic kidney disease. (2016) (2)
Measurement of the potential for cadaveric organ retrieval in New South Wales, Australia. (1993) (2)
Setting the limit for living kidney donation-how big is too big? (2017) (2)
The candle illuminating the pathway to tolerance? (2012) (2)
A Peripheral Blood Gene Expression Signature for Subclinical Acute Rejection and Associated Long-Term Graft Injury.: Abstract# 1328 (2014) (2)
F1000Prime recommendation of A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety. (2012) (2)
Elimination of nonimmunological causes of cadaveric renal allograft loss--an attainable goal? (1990) (2)
Sirolimus and everolimus for kidney transplant recipients (2003) (2)
An Overview of Transplantation in Australia (1995) (2)
Post‐Transplant Lymphoproliferative Disorder (2013) (2)
Despite the best intentions cancer is transmissible by transplantation. (2012) (2)
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. (2019) (2)
Renal transplantation--an effective therapy in the 1990s. (1992) (2)
Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD: Accurate or Not? Reply (2019) (2)
Nonutilization of Kidneys From Donors After Circulatory Determinant of Death (2022) (1)
T-cell antigen receptor V alpha gene expression in rejecting renal allografts. (1992) (1)
SAT-022 ASSOCIATION BETWEEN PUBLICATION OF THE INITIATING DIALYSIS EARLY AND LATE (IDEAL) STUDY AND CHANGE IN DIALYSIS INITIATION PRACTICE (2019) (1)
Sensitization and renal transplantation in New South Wales. (1989) (1)
DNA typing: an important step forward? (1992) (1)
Can the demand for cadaver kidneys be met? (1992) (1)
Hospital-acquired Pneumocystis pneumonia: a renewed concern? (2014) (1)
Preface. Renal Transplantation--new insights for a new decade. (2010) (1)
Not all donors are equal. (2006) (1)
Survival of DNA HLA-DR typed and matched eadaver kidney transplants (1992) (1)
The global role of kidney transplantation. (2012) (1)
Patientsʼ Attitudes Towards Living Kidney Donation: Systematic Review and Thematic Synthesis of Qualitative Research.: Abstract# B832 (2014) (1)
Identification of a Molecular Signature to Predict the Progression of Kidney Fibrosis Post Transplantation. (2014) (1)
Scoring arteriolar hyalinosis in renal allograft biopsies: so important and yet so tricky (2006) (1)
Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients (2018) (1)
IMPACT OF KIDNEY TRANSPLANTATION AND CANCER CO-MORBIDITY COMPARED WITH CANCER ALONE ON EXPECTED SURVIVAL A REGISTRY ANALYSIS FROM AUSTRALIA AND NEW ZEALAND: 290 (2008) (1)
Exercise Training in Solid Organ Transplant Recipients - A Systematic Review: 991 (2012) (1)
COVID-19: a year on. (2020) (1)
Message from the editor-in-chief. (2015) (1)
Peripheral Blood miRNA Signature Predicts Progression of Kidney Fibrosis Post-Transplantation.: Abstract# 1331 (2014) (1)
The global role of kidney transplantation. (2012) (1)
Authors' Reply. (2019) (1)
315.16: Development of a Registry for Gender Equity Analysis (ASTREG-WIT-KT) in Asian-Pacific Countries (2022) (1)
Factors Associated with Time to Deceased Donor Renal Transplant Waitlisting or Living Donor Transplantation in Australia (2018) (1)
Comparison of serological class II typing with DNA-DR and DNA-DQ typing of kidney donors and recipients. (1990) (1)
Utilising Exome Sequencing to Identify Nephronophthisis Mutations Within An Australian Clinical Cohort (2014) (1)
Transplant Professionals’ Attitudes and Approaches to the Living Kidney Donor-Recipient Relationship: Interview study (2017) (1)
perspective of the World Marrow Donor Association Remuneration of hematopoietic stem cell donors: principles and (2011) (1)
ASSESSMENT OF EVEROLIMUS IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS: THE ASCERTAIN STUDY: 1646 (2008) (1)
Positional ischaemia of transplant kidney: A rare cause of early graft dysfunction (2019) (1)
Chapter 4 – The Recipient of a Renal Transplant (2008) (1)
The IDEAL trial in Australia and New Zealand: Clinical and Economic impact. (2021) (1)
Gender Disparity in Asian-Pacific Countries: An Analysis of the ASTREG-WIT-KT Registry (2022) (1)
Normoglycaemia in dogs after splenic vein reflux of autografted pancreatic microfragments. (1993) (1)
Transplantation: The global role of kidney transplantation (2012) (1)
Global coding system for human cells and tissues for transplantation. (2008) (1)
Reply to “Review of Living Kidney Donor Guidelines is Out of Date Before Publication” (2012) (1)
Donor derived disease - who to notify? (2021) (1)
Ethical Issues Regarding the Use of Human Tissues and Cells (2012) (1)
The Destiny of Articles When Pairing “Traditional”—With Open Access Sibling Journals (2022) (0)
Original Investigation Reduced Estimated GFR and Cancer Mortality (2014) (0)
Everyoneʼs Got Their Own Threshold. Nephrologistsʼ Perspectives On Patient Eligibility and Access to Living Donor Kidney Transplantation.: Abstract# B836 (2014) (0)
Commentary: harmonizing the regulators. (2005) (0)
Colorectal Cancer after Kidney Transplantation: Risks and Implications for Screening and Early Detection (2011) (0)
AN OBSERVATIONAL, NON-INTERVENTIONAL, MULTICENTRE, MULTINATIONAL REGISTRY OF PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME (aHUS): INITIAL CHARACTERISTICS OF THE AUSTRALIAN COHORT (2014) (0)
Establishing consensus on ethics, traceability and biovigilance for medical products of human origin (2021) (0)
PRE-KIDNEY TRANSPLANT RISK FACTORS AND POST-TRANSPLANT CARDIOVASCULAR AND ALL-CAUSE MORTALITY: 1310 (2010) (0)
Buyer beware transplantation. (2016) (0)
Identifying principles and strategies for involving patients and caregivers in research in chronic kidney disease: A report of three workshops (2018) (0)
Tacrolimus: A Clinician's Perspective on What is Important (2013) (0)
Establishing Guidelines for Organ Donation Systems (2023) (0)
Chapter 4 – The Recipient of a Kidney Transplant (2014) (0)
Kinetics of increased class II antigen expression in canine pancreas allograft rejection. (1989) (0)
Contributors (1973) (0)
Tissue typing--minimum requirements for clinical transplantation. (1992) (0)
Sirolimus therapy after early cyclosporine withdrawal reduces the risk of malignancy at 5 years after renal transplantation (2006) (0)
Research priorities in chronic kidney disease: a priority setting partnership (2014) (0)
Transplantation: To accept, or not to accept—that is the question (2014) (0)
XXII International Congress of The Transplantation Society. (2009) (0)
Faculty Opinions recommendation of Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials. (2013) (0)
LIMB SALVAGE IN NON-TRANSPLANTATION AND TRANSPLANTATION POPULATION: 1547 (2008) (0)
MONOCLONAL AND POLYCLONAL ANTIBODY INDUCTION THERAPY FOR PANCREAS AND KIDNEY/PANCREAS TRANSPLANTATION: A META-ANALYSIS OF RANDOMISED TRIALS (2004) (0)
Pre‐emptive transplants: right for some, but the wrong question? (2023) (0)
Prolonged Cardiac Allograft Survival in BAFF-Transgenic Mice Associated with Increased Tregs: 956 (2012) (0)
OPTIMIZING SERUM CREATININE MONITORING FOR THE RAPID DETECTION OF COMPLICATIONS IN THE EARLY POST-KIDNEY TRANSPLANT PERIOD: 1285 (2010) (0)
Faculty Opinions recommendation of Treatment for lupus nephritis. (2013) (0)
The Relative Benefits and Costs of Luminex Testing for Preformed Donor Specific Anti-Human Leukocyte Antigen Antibodies in Kidney Transplantation.: Abstract# A454 (2014) (0)
PREDICTION OF SERUM CREATININE IN THE FIRST MONTH FOLLOWING UNCOMPLICATED KIDNEY TRANSPLANTATION: 1272 (2010) (0)
China and the organ trade (2013) (0)
Unravelling the connections between donor specific antibodies and renal allograft pathology. (2013) (0)
WESTRAN FETAL PIG PANCREAS FRAGMENT TRANSPLANTS PROVIDE FUNCTION FOLLOWING TOTAL NATIVE PANCREATECTOMY.: 026 (2003) (0)
Donor sepsis (2005) (0)
SCREENING FOR FUNCTIONAL ASYMMETRY IN POTENTIAL LIVING KIDNEY DONORS: 1111 (2008) (0)
The global role of kidney transplantation. (2012) (0)
Class II DNA polymorphisms and renal allograft outcome. (1989) (0)
Proteomic Analysis Identified Urine Proteins Predictive of Chronic Allograft Injury.: Abstract# 1334 (2014) (0)
Not that day … (2009) (0)
Changing the regimen. (1995) (0)
Transplantation Direct: TTS eJournal Progress Update. (2020) (0)
Guest Editorial: The Role of Scientific Societies (2010) (0)
THE IMPACT OF PRE-TRANSPLANT ANTI-HLA AND MICA ANTIBODIES ON LONG-TERM GRAFT OUTCOMES: 2153 (2008) (0)
Lymph node implantation inducing hyperacute rejection in canine pancreas transplantation. (1992) (0)
National and International Transplant Management and Oversight (2014) (0)
LIFE YEARS GAIN AND COST-SAVINGS ON THE KIDNEY TRANSPLANT WAITING LIST: 1327 (2010) (0)
Simultaneous pancreas and kidney transplantation: a review of outcome from a single center (1999) (0)
THE NATURAL HISTORY OF CHRONIC ALLOGRAFT NEPHROPATHY AFTER SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION (SPK): 036 (2003) (0)
The global role of kidney transplantation. (2012) (0)
Faculty Opinions recommendation of Rituximab in children with resistant idiopathic nephrotic syndrome. (2012) (0)
Urine pH in clinical pancreas transplantation : IX th Scientific meeting of the Transplantation Society of Australia and New Zealand, Canberra, Australia, April 10-12, 1991 (1992) (0)
Cerebrovascular Disease in Hypertension (2007) (0)
Opinions of Transplant Nephrologists and Surgeons On Reimbursement, Compensation and Incentives for Living Kidney Donors.: Abstract# B828 (2014) (0)
IMMUNOSUPPRESSIVE EFFECT OF TOTAL LYMPHOID IRRADIATION USED IN TOLERANCE INDUCTION PROTOCOLS IN DOGS: 1489 (2008) (0)
Evaluation of sequential fine-needle aspiration biopsy in the assessment of kidney and pancreas allograft rejection in dogs. (1990) (0)
Management Guidelines Peritransplantation (2009) (0)
Blood pressure and vascular complications of diabetes (2001) (0)
Balancing sensitivity and specificity – unfolding crossmatch biology in renal transplantation * (2012) (0)
Clinical islet transplantation: a triumph of hope over experience (2002) (0)
Dying of Cancer With Kidney Disease. (2022) (0)
Results of principal endpoint studies, ongoing studies and expected future results (2002) (0)
President of the Transplantation Society, 2010-2012: Professor Gerhard Opelz. (2013) (0)
IN VIVO & IN VITRO DATA SUGGEST HUMAN PANCREATIC ISLET TRANSPLANTATION IS PROTHROMBOGENIC DESPITE ANTICOAGULATION (2004) (0)
DNA typing: an important step forward? Collaborative Transplant Study. (1992) (0)
Clinical islet transplantation: a triumph of hope over experience (2002) (0)
Neuroendocrine tumour of the pancreatic allograft in a kidney - pancreas recipient (2012) (0)
Induction of allogeneic islet tolerance in a large-animal model. (2000) (0)
IS SCREENING FOR CERVICAL CANCER IN KIDNEY TRANSPLANT RECIPIENTS COST-EFFECTIVE? THE COSTS AND HEALTH BENEFITS OF SCREENING FOR CERVICAL CANCER IN WOMEN WITH KIDNEY TRANSPLANTS: 848 (2008) (0)
MICROARRAYS DETECT PROFIBROTIC GENE EXPRESSION IN HUMAN RENAL ALLOGRAFTS EARLY AFTER TRANSPLANTION ASSOCIATED WITH CHRONIC ALLOGRAFT NEPHROPAY (CAN). (2006) (0)
Excellent SPK Transplantation Outcomes Despite Vast Distances: An Australian Experience: 1037 (2012) (0)
Mega-meta-analysis-can the results be trusted? (2001) (0)
Desperation, Despair, and Debasement: Thematic Synthesis of Qualitative Research on the Experiences of Commercial Kidney Donors: 942 (2012) (0)
INTERLEUKIN-2 RECEPTOR ANTAGONISTS VERSUS ATG FOR KIDNEY TRANSPLANT RECIPIENTS; AN UPDATED COCHRANE SYSTEMATIC REVIEW.: 1508 (2010) (0)
Looking Ahead (2002) (0)
Clinical Practice Guidelines on Waitlisting for Kidney Transplantation: A Systematic Review: 1247 (2012) (0)
In Memoriam: Professor Henrik Ekberg of Lund University and President Elect of The Transplantation Society. (2013) (0)
Advantages and disadvantages of pancreas transplantation : IX th Scientific meeting of the Transplantation Society of Australia and New Zealand, Canberra, Australia, April 10-12, 1991 (1992) (0)
Exercise Training and Dietary Program in Kidney Transplant Recipients: 1432 (2012) (0)
Urine pH in clinical pancreas transplantation. (1992) (0)
Blood pressure lowering treatment and the prevention of stroke in the diabetic patient (2004) (0)
Public Attitudes and Beliefs About Living Kidney Donation: Focus Group Study.: Abstract# B839 (2014) (0)
The Transplantation Society recognition awards 2008. (2008) (0)
Controversies in Living Kidney Donation. (2022) (0)
Assessment of donors with sub‐optimal kidney function/structure (2005) (0)
Looking Ahead (2008) (0)
The evolution of kidney transplantation (2015) (0)
Transplant Commercialism - Is It Only About The Money?: Abstract# D2696 (2014) (0)
CANCER SCREENING PRACTICES BY TRANSPLANT PHYSICIANS: WHAT DO PHYSICIANS SCREEN FOR AND WHY?: 850 (2008) (0)
MP822DEVELOPING CONSENSUS BASED PRIORITY OUTCOME DOMAINS FOR TRIALS IN KIDNEY TRANSPLANTATION: A MULTINATIONAL DELPHI SURVEY WITH PATIENTS, CAREGIVERS AND HEALTH PROFESSIONALS (2017) (0)
T-cell receptor Vγ and Vδ gene expression in serial renal allograft biopsies (1994) (0)
333.4: Capacity building and training on organ transplantation in Myanmar through Myanmar-Korea joint efforts. (2019) (0)
Variations in Risk of Cancer and Death From Cancer According to Kidney Allograft Function, Graft Loss, and Return to Dialysis. (2023) (0)
MYCOPHENOLATE MOFETIL REDUCES THE HISTOLOGICAL EXPRESSION OF CHRONIC ALLOGRAFT NEPHROPATHY. (2006) (0)
IMMUNOCOMPETENCE OF CANINE HEMATOPOIETIC CHIMERAS WITH LONG-TERM RENAL ALLOGRAFTS: 1482 (2008) (0)
Long-Term Renal Function of Living Kidney Donors- A Prospective Cohort Study.: Abstract# A294 (2014) (0)
CHIMERIC TOLERANCE INDUCED BY TOTAL LYMPHOID IRRADIATION AND DONOR SPECIFIC BONE MARROW INFUSION IN DLA-DP MATCHED DOGS: 653 (2008) (0)
Acknowledgement to referees (2011) (0)
From the Wright Brothers to the A380: Developing Transplantation Takes Teams of Teams. (2022) (0)
The impact of screening for BK virus in renal allograft recipients (2005) (0)
Combined pancreas and kidney transplantation: a pilot study. (1989) (0)
RISK OF CUTANEOUS MELANOMA DOES NOT INCREASE OVER TIME AFTER RENAL TRANSPLANTATION: 846 (2008) (0)
IL2 receptor antagonists for renal transplant recipients: An updated meta-analysis of randomised trials (2006) (0)
SUN-328 ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY: A POTENTIALLY REVERSIBLE CAUSE OF CHRONIC KIDNEY DISEASE IN THE PRE AND POST TRANSPLANT SETTING (2019) (0)
Donor cancer (2005) (0)
INVASIVE FUNGAL INFECTION AFTER RENAL TRANSPLANTATION (2011) (0)
Are nonesterified fatty acids protective in chronic allograft nephropathy? (2013) (0)
INTEGRATIVE ANALYSIS OF PROGNOSTIC BIOMARKERS FOR ACUTE REJECTION IN KIDNEY TRANSPLANT RECIPIENTS (2020) (0)
One-Time Faecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with Chronic Kidney Disease (Detect Study) (2018) (0)
Effects of different antihypertensive drugs in reducing cardiovascular mortality and morbidity (2001) (0)
SP734THE BREADTH AND CONSISTENCY OF OUTCOMES REPORTED IN RANDOMISED TRIALS CONDUCTED IN ADULT KIDNEY TRANSPLANT RECIPIENTS (2017) (0)
THE HEALTH AND ECONOMIC IMPACT OF HUMAN PAPILLOMAVIRUS VACCINATION IN KIDNEY TRANSPLANT RECIPIENTS: 849 (2008) (0)
URINE CYTOLOGY AS A SCREENING TOOL FOR BK VIRUS NEPHROPATHY: PRELIMINARY FINDINGS IN 350 SAMPLES (2014) (0)
Ronald Lawrie Huckstep CMG, MD, FRCS, FRACS (2015) (0)
Percutaneous fine needle aspiration biopsy in clinical pancreas transplantation (1992) (0)
H. Myron Kaufman (1933–2007) Medical Director and Senior Scientist of UNOS: Transplant Surgeon and Friend (2008) (0)
President's Address. The Transplantation Society-Vancouver 2010. (2010) (0)
SAT-316 COMPARISON OF PATIENT AND GRAFT OUTCOMES BETWEEN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANT RECIPIENTS AND NON DIABETIC KIDNEY TRANSPLANT RECIPIENTS (2020) (0)
IMPACT OF CANCER ON SURVIVAL AFTER KIDNEY TRANSPLANTATION: 291 (2008) (0)
Enteric Leaks from Simultaneous Pancreas Kidney Transplantation at a Single Centre: Risk Factors and Management Over a 20-Year Period (2020) (0)
Cells infiltrating heart allografts: specificity and function. (1990) (0)
President's Address: International Liver Transplantation Society. (2015) (0)

This paper list is powered by the following services:

Other Resources About Jeremy Chapman

en.wikipedia.org

What Schools Are Affiliated With Jeremy Chapman?

Jeremy Chapman is affiliated with the following schools:

Jeremy Chapman's Academic­Influence.com Rankings